Skip to main content
GRCE logo

GRCE · Grace Therapeutics, Inc.

Track GRCE — free
$2.20 +0.06 (+2.80%) At close · Aug 21
Market Cap
$46.28M
Shares
21.04M

Grace Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Grace Therapeutics, Inc. (GRCE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Annual General Meeting
Investor event
2026-09-17
Annual Meeting of Shareholders
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY23 · Q3
2023-02-14
Grace Therapeutics, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.52
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-14
Grace Therapeutics, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.66
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-11
Grace Therapeutics, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-0.61
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-21
Grace Therapeutics, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-14
Grace Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$
▼ 100% YoY
Diluted EPS
$-0.54
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-10
Grace Therapeutics, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-0.18
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-12
Grace Therapeutics, Inc. Q1 FY2022 Earnings Call
Diluted EPS
$-0.72
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-22
Grace Therapeutics, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q1
2020-08-13
Grace Therapeutics, Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-06-29
Grace Therapeutics, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–11 of 11 earnings calls
Key facts CIK 1444192 CUSIP 00439U104 13F (30d) 33 filings 33 filers Visit website Investor relations